MedImmune announced that Ron Laufer has been appointed senior managing director of MedImmune Ventures, the company’s venture capital arm.
Laufer brings more than 15 years of experience to MedImmune Ventures as both a physician and a venture capitalist. He was a co-founder of Lilly Ventures, Eli Lilly and Company’s corporate venture capital fund. He was also a managing director for Visium Asset Management, a healthcare-focused investment firm, where he established the firm’s venture capital team. -PR Newswire
